2026-08378Notice

FDA Keeps Pharmacy Compounding Experts On Board

Published Date: 4/30/2026

Notice

Summary

The FDA is renewing the Pharmacy Compounding Advisory Committee for two more years, keeping it active until April 25, 2028. This committee helps the FDA make smart decisions about safely mixing medicines for patients. If you’re involved in pharmacy or drug safety, this renewal means the expert advice will keep flowing without interruption.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
4/30/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register